https://www.selleckchem.com/pr....oducts/Mycophenolate
Using the strongest predictors (i.e., d-AMY and CRP), we established a criterion for no CR-POPF d-AMY levels less then 350 IU/l and CRP levels less then 14 mg/dl on POD3. The incidence rates of CR-POPF were 6%, 38%, and 88% in patients who fulfilled both of (n = 149), each of (n = 74), and none of (n = 77) the two factors, respectively. In the internal validation cohort, the positive predictive value of CR-POPF was 89%. CONCLUSIONS A simple two-factor criterion available on POD3 after PD has a reliable predict
Like
Comment
Share
